The average price target for Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) has increased from $103.05 to $133, ...

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA orphan designation, ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Inc. (TSVT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi ...

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received a consensus rating of “Hold” from the eight ...

In this article, we have named the day’s worst performers and detailed the reasons behind their drop. To come up with the list, we only considered those with $2 billion in market capitalization and $5 ...